FIELD: medicine.
SUBSTANCE: pharmaceutical composition in the form of a tablet contains a core coated with a separating layer and an enteric coating. The core contains an active substance, sodium rabeprazole, and additives - calcium carbonate, lactose, starch, hydroxypropylmethyl cellulose, stearic acid salt in the amounts specified in the patent claim. What is also described is a method for producing the pharmaceutical composition of rabeprazole. The invention enables to extend the range of medical products applicable for treating gastric ulcer.
EFFECT: low in foreign impurities and having good stability.
3 cl, 3 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF GASTRIC AND DUODENUM ULCER IN FORM OF SOLID GELATIN CAPSULES, WHICH CONTAINS RABEPRAZOLE OR ITS DERIVATIVES, AND METHOD OF ITS OBTAINING | 2007 |
|
RU2414889C2 |
| COMBINED PREPARATION OF MOSAPRIDE AND RABEPRAZOLE | 2016 |
|
RU2697836C2 |
| COMBINED PHARMACEUTICAL WITH TABLET IN CORE, CONTAINING MOSAPRIDE AND RABEPRAZOLE | 2018 |
|
RU2753697C1 |
| METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION CONTAINING A NON-STEROIDAL ANTI-INFLAMMATORY DRUG, A PROTON PUMP INHIBITOR AND AN ANTACID, A PHARMACEUTICAL COMPOSITION CONTAINING A NON-STEROIDAL ANTI-INFLAMMATORY DRUG, A PROTON PUMP INHIBITOR AND AN ANTACID, THE USE OF A PHARMACEUTICAL COMPOSITION | 2021 |
|
RU2790691C1 |
| PHARMACEUTICAL COMPOSITION HAVING ANTIULCER ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2736184C1 |
| COMPOSITIONS AND METHODS FOR GASTRIC ACID SECRETION INHIBITION WITH USING SMALL DICARBOXYLIC ACID DERIVATIVES IN COMBINATION WITH PPI | 2007 |
|
RU2467747C2 |
| PHARMACEUTICAL COMPOSITION FOR GASTRIC AND/OR DUODENAL ULCER | 2010 |
|
RU2448702C2 |
| COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2436580C1 |
| AGENT FOR TREATMENT OF PROSTATE DISEASE | 2005 |
|
RU2278681C1 |
| METHOD FOR PRODUCING TABLETTED BIVALENT CHEMICAL CHOLERA VACCINE | 2014 |
|
RU2563620C2 |
